Marvell (MRVL) PT Raised to $50 at Rosenblatt on Shift to 5nm

Go back to Marvell (MRVL) PT Raised to $50 at Rosenblatt on Shift to 5nm

Raymond James Reiterates Market Perform Rating on Marvell (MRVL) Following Mixed 2Q

August 28, 2020 7:38 AM EDT

Raymond James analyst Chris Caso reiterated a Market Perform rating on Marvell (NASDAQ: MRVL) following the company's 2Q earnings report. July quarter revenue of $727.3 million was up 5% q/q and 11% y/y and came in modestly above the midpoint of guidance.... More

Stifel Reiterates Buy Rating on Marvell (MRVL) Following 2Q Report

August 28, 2020 7:32 AM EDT

Stifel analyst Tore Svanberg reiterated a Buy rating and $43.00 price target on Marvell (NASDAQ: MRVL) following the company's 2Q earnings report. Revenue was $727.3mn vs. the Street estimate of $720.7mn. Non-GAAP EPS was $0.21, +$0.01 above the Street consensus estimate of $0.20.

Svanberg... More